Drugs@FDA: FDA Approved Drug Products

Home | Previous Page

Abbreviated New Drug Application (ANDA): 203177
Company: XELLIA PHARMS APS
Drug Name Active Ingredients Strength Dosage Form/Route Marketing Status TE Code RLD RS
BACITRACIN BACITRACIN 50,000 UNITS/VIAL INJECTABLE;INJECTION Prescription AP No No
Original Approvals or Tentative Approvals
Action Date Submission Action Type Submission Classification Review Priority; Orphan Status Letters, Reviews, Labels, Patient Package Insert Notes Url
08/25/2014 ORIG-1 Approval

Label is not available on this site.

BACITRACIN

INJECTABLE;INJECTION; 50,000 UNITS/VIAL
TE Code = AP

Drug Name Active Ingredients Strength Dosage Form/Route Marketing Status RLD TE Code Application No. Company
BACIIM BACITRACIN 50,000 UNITS/VIAL INJECTABLE;INJECTION Prescription No AP 064153 X GEN PHARMS
BACITRACIN BACITRACIN 50,000 UNITS/VIAL INJECTABLE;INJECTION Prescription No AP 206719 AKORN
BACITRACIN BACITRACIN 50,000 UNITS/VIAL INJECTABLE;INJECTION Prescription No AP 065116 FRESENIUS KABI USA
BACITRACIN BACITRACIN 50,000 UNITS/VIAL INJECTABLE;INJECTION Prescription No AP 060733 PHARMACIA AND UPJOHN
BACITRACIN BACITRACIN 50,000 UNITS/VIAL INJECTABLE;INJECTION Prescription No AP 090211 SAGENT STRIDES
BACITRACIN BACITRACIN 50,000 UNITS/VIAL INJECTABLE;INJECTION Prescription No AP 203177 XELLIA PHARMS APS

Note: If you need help accessing information in different file formats, see Instructions for Downloading Viewers and Players.
Language Assistance Available: Español | 繁體中文 | Tiếng Việt | 한국어 | Tagalog | Русский | العربية | Kreyòl Ayisyen | Français | Polski | Português | Italiano | Deutsch | 日本語 | فارسی | English